glp 1 meds for addiction GLP-1 medications are getting attention their potential in care. Here's what the research is finding. #AddictionTreatment #GLP1 #EmergingResearch The role of glucagon‐like peptide

Research involving CJC-1295 no DAC Ipamorelin peptide blend examines interaction with GHRH- and ghrelin-related receptor pathways, allowing for the study of coordinated endocrine signaling processes

People with vitamin C deficiency have a higher risk of cardiovascular disease

Non-melanoma skin cancer deaths rise Non-melanoma skin cancer deaths rise In Clinical news Follow this topic Bookmark Record learning outcomes Research suggests that deaths from non-melanoma skin cancer (NMSC) could soon overtake malignant melanoma (MM) mortality in England and Scotland

We failed to test the effects of retatrutide on the sinus node of man directly